News from eisai europe limited
A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages
03 Mar, 2011, 01:00 GMT Study Published in the Lancet Shows Eisai's Halaven(TM)(Eribulin) Significantly Improves Overall Survival Compared With Current Treatments in Heavily Pre-Treated Metastatic Breast Cancer
- Updated Phase III Data confirms Significant Survival Benefit Ahead of Impending European Launch New data supporting the role of Eisai's Halaven(TM) ...
25 Jan, 2011, 07:37 GMT Eisai to Submit Marketing Authorization Applications in the U.S. and EU for Perampanel as Adjunctive Therapy for Partial Seizures in Patients with Epilepsy
- Submissions Planned for First Quarter of Fiscal 2011 Eisai announced today that it will submit Marketing Authorization Applications in the United...